{"id":505,"date":"2017-08-07T12:02:00","date_gmt":"2017-08-07T12:02:00","guid":{"rendered":"http:\/\/rushmore.wpcolorlab.com\/?page_id=505"},"modified":"2021-08-09T03:22:45","modified_gmt":"2021-08-09T03:22:45","slug":"journal-articles","status":"publish","type":"page","link":"https:\/\/oncovix.mpois.com\/?page_id=505","title":{"rendered":"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA"},"content":{"rendered":"<p><section class=\"kc-elm kc-css-503107 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-170467 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-475638 kc_text_block\"><\/p>\n<p>Destacada en distintas publicaciones por ser 1 de las 3 inmunoterapias (junto a T-CAR e inhibidores de checkpoints) con mayor respaldo, as\u00ed como alta precisi\u00f3n, personalizada, de m\u00ednimas reacciones adversas y de costo m\u00e1s accesible en comparaci\u00f3n a otras inmunoterapias.<\/p>\n<p>\n<\/div><\/div><\/div><\/div><\/div><\/section><section class=\"kc-elm kc-css-79247 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-914480 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\">\n    <div class=\"rushmore-content-area section-journal-papers kc-elm kc-css-880883\">\n    <nav class=\"journal-papers-nav\">\n        <ul class=\"journal-papers-nav-list list-inline\" role=\"tablist\"><li role=\"presentation\" class=active><a href=\"#2019\" class=\"link-prev_def\" aria-controls=\"2019\" role=\"tab\" data-toggle=\"tab\">2019<\/a><\/li><li role=\"presentation\" ><a href=\"#2018\" class=\"link-prev_def\" aria-controls=\"2018\" role=\"tab\" data-toggle=\"tab\">2018<\/a><\/li><li role=\"presentation\" ><a href=\"#2016-2017\" class=\"link-prev_def\" aria-controls=\"2016-2017\" role=\"tab\" data-toggle=\"tab\">2016-2017<\/a><\/li><\/ul>\n    <\/nav>\n    <div class=\"journal-papers-mound-wrap tab-content\"><div class=\"journal-papers-mound tab-pane fade in active\" id=\"2019\" role=\"tabpanel\"><nav class=\"journal-papers-mound-nav\"><h3 class=\"nav-title\">2019<\/h3><\/nav>\n                <div class=\"journal-papers-list\">\n                    <div class=\"journal-papers\">\n                        <div class=\"row\">\n                            <div class=\"col-sm-3\">\n                                <p class=\"jp-name\">Robert A. Belderbos,1,2 Joachim G.J.V. Aerts,1,2 and Heleen Vroman1,2<\/p>\n                            <\/div>\n                            <div class=\"col-sm-6\">\n                                <div class=\"journal-papers-meta\">\n                                    <p>Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment (2019):<em> Enhancing Dendritic Cell Therapy\r\nin Solid Tumors<\/em> Department of Pulmonary Medicine, Erasmus MC Rotterdam, the Netherlands; 2Erasmus MC Cancer Institute, Erasmus MC Rotterdam, the Netherlands<\/p>\n                                <\/div>\n                            <\/div><div class=\"col-sm-3\">\n                                <div class=\"journal-papers-doi\"><span>DOI:<\/span> <a href=\"https:\/\/www.cell.com\/molecular-therapy-family\/oncolytics\/pdfExtended\/S2372-7705(19)30037-3\" target=\"_blank\">Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment (2019):<\/a><\/div>\n                            <\/div><\/div>\n                    <\/div><!-- \/.journal-papers -->\n                <\/div><\/div><div class=\"journal-papers-mound tab-pane fade \" id=\"2018\" role=\"tabpanel\"><nav class=\"journal-papers-mound-nav\"><h3 class=\"nav-title\">2018<\/h3><\/nav>\n                <div class=\"journal-papers-list\">\n                    <div class=\"journal-papers\">\n                        <div class=\"row\">\n                            <div class=\"col-sm-3\">\n                                <p class=\"jp-name\">By Hanne Locy, Sarah Melhaoui, Sarah K. Maenhout and Kris Thielemans<\/p>\n                            <\/div>\n                            <div class=\"col-sm-6\">\n                                <div class=\"journal-papers-meta\">\n                                    <p>Dendritic Cells: The Tools for Cancer Treatment:<em> Submitted: April 6th 2018Reviewed: June 4th 2018Published: November 5th 2018\r\n\r\nDOI: 10.5772\/intechopen.79273<\/em> Dendritic Cells: The Tools for Cancer Treatment<\/p>\n                                <\/div>\n                            <\/div><div class=\"col-sm-3\">\n                                <div class=\"journal-papers-doi\"><span>DOI:<\/span> <a href=\"https:\/\/www.intechopen.com\/chapters\/63198\" target=\"_blank\">Hanne Locy, Sarah Melhaoui, Sarah K. Maenhout and Kris Thielemans (November 5th 2018). Dendritic Cells: The Tools for Cancer Treatment, Dendritic Cells, Svetlana P. Chapoval, IntechOpen, DOI: 10.5772\/intechopen.79273. Available from: https:\/\/www.intechopen.com\/chapters\/63198<\/a><\/div>\n                            <\/div><\/div>\n                    <\/div><!-- \/.journal-papers -->\n                <\/div><\/div><div class=\"journal-papers-mound tab-pane fade \" id=\"2016-2017\" role=\"tabpanel\"><nav class=\"journal-papers-mound-nav\"><h3 class=\"nav-title\">2016-2017<\/h3><\/nav>\n                <div class=\"journal-papers-list\">\n                    <div class=\"journal-papers\">\n                        <div class=\"row\">\n                            <div class=\"col-sm-3\">\n                                <p class=\"jp-name\">Abhishek D. Garg\r\nPierre G. Coulie\r\nBenoit J. Van den Eynde\r\nPatrizia Agostinis\r\n<\/p>\n                            <\/div>\n                            <div class=\"col-sm-6\">\n                                <div class=\"journal-papers-meta\">\n                                    <p>Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.:<em> Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape<\/em> The field of cancer immunotherapy is experiencing a renaissance spearheaded by ICIs and ACTs.<\/p>\n                                <\/div>\n                            <\/div><div class=\"col-sm-3\">\n                                <div class=\"journal-papers-doi\"><span>DOI:<\/span> <a href=\"https:\/\/doi.org\/10.1016\/j.it.2017.05.006\" target=\"_blank\">https:\/\/doi.org\/10.1016\/j.it.2017.05.006<\/a><\/div>\n                            <\/div><\/div>\n                    <\/div><!-- \/.journal-papers -->\n                <\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":250,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA - Oncovix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA - Oncovix\" \/>\n<meta property=\"og:description\" content=\"Destacada en distintas publicaciones por ser 1 de las 3 inmunoterapias (junto a T-CAR e inhibidores de checkpoints) con mayor respaldo, as\u00ed como alta precisi\u00f3n, personalizada, de m\u00ednimas reacciones adversas y de costo m\u00e1s accesible en comparaci\u00f3n a otras inmunoterapias. 2016-2017 2014-2015 2010-2011 2000-2005 1999-1995 1990-1194 1985-1989 2016-2017 [287] A. Teo, K. H. H. Li, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncovix.mpois.com\/?page_id=505\" \/>\n<meta property=\"og:site_name\" content=\"Oncovix\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-09T03:22:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i2.wp.com\/oncovix.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg?fit=1923%2C450&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1923\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=505\",\"url\":\"https:\/\/oncovix.mpois.com\/?page_id=505\",\"name\":\"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA - Oncovix\",\"isPartOf\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=505#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=505#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg\",\"datePublished\":\"2017-08-07T12:02:00+00:00\",\"dateModified\":\"2021-08-09T03:22:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=505#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oncovix.mpois.com\/?page_id=505\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=505#primaryimage\",\"url\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg\",\"contentUrl\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg\",\"width\":1923,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=505#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/oncovix.mpois.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oncovix.mpois.com\/#website\",\"url\":\"https:\/\/oncovix.mpois.com\/\",\"name\":\"Oncovix\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oncovix.mpois.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oncovix.mpois.com\/#organization\",\"name\":\"Oncovix\",\"url\":\"https:\/\/oncovix.mpois.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg\",\"contentUrl\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg\",\"width\":1125,\"height\":349,\"caption\":\"Oncovix\"},\"image\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA - Oncovix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_ES","og_type":"article","og_title":"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA - Oncovix","og_description":"Destacada en distintas publicaciones por ser 1 de las 3 inmunoterapias (junto a T-CAR e inhibidores de checkpoints) con mayor respaldo, as\u00ed como alta precisi\u00f3n, personalizada, de m\u00ednimas reacciones adversas y de costo m\u00e1s accesible en comparaci\u00f3n a otras inmunoterapias. 2016-2017 2014-2015 2010-2011 2000-2005 1999-1995 1990-1194 1985-1989 2016-2017 [287] A. Teo, K. H. H. Li, [&hellip;]","og_url":"https:\/\/oncovix.mpois.com\/?page_id=505","og_site_name":"Oncovix","article_modified_time":"2021-08-09T03:22:45+00:00","og_image":[{"width":1923,"height":450,"url":"https:\/\/i2.wp.com\/oncovix.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg?fit=1923%2C450&ssl=1","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/oncovix.mpois.com\/?page_id=505","url":"https:\/\/oncovix.mpois.com\/?page_id=505","name":"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA - Oncovix","isPartOf":{"@id":"https:\/\/oncovix.mpois.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oncovix.mpois.com\/?page_id=505#primaryimage"},"image":{"@id":"https:\/\/oncovix.mpois.com\/?page_id=505#primaryimage"},"thumbnailUrl":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg","datePublished":"2017-08-07T12:02:00+00:00","dateModified":"2021-08-09T03:22:45+00:00","breadcrumb":{"@id":"https:\/\/oncovix.mpois.com\/?page_id=505#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncovix.mpois.com\/?page_id=505"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/oncovix.mpois.com\/?page_id=505#primaryimage","url":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg","contentUrl":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2017\/08\/conf_talk-2.jpg","width":1923,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/oncovix.mpois.com\/?page_id=505#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncovix.mpois.com\/"},{"@type":"ListItem","position":2,"name":"LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA"}]},{"@type":"WebSite","@id":"https:\/\/oncovix.mpois.com\/#website","url":"https:\/\/oncovix.mpois.com\/","name":"Oncovix","description":"","publisher":{"@id":"https:\/\/oncovix.mpois.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncovix.mpois.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/oncovix.mpois.com\/#organization","name":"Oncovix","url":"https:\/\/oncovix.mpois.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/","url":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg","contentUrl":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg","width":1125,"height":349,"caption":"Oncovix"},"image":{"@id":"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/505"}],"collection":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=505"}],"version-history":[{"count":2,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/505\/revisions"}],"predecessor-version":[{"id":2365,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/505\/revisions\/2365"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/media\/250"}],"wp:attachment":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}